Formulation Development Applications & Studies

  1. Shining A Light On Dark Data 6/11/2026

    Centralizing data unlocks faster insights, reduces duplicated effort, and improves compliance. By overcoming silos and “dark data,” organizations can enable efficient search, reuse, and analysis.

  2. Direct qPCR Amplification From Human Urine Samples 6/9/2026

    Extraction-free qPCR enables faster, lower-cost detection of UTI-associated bacteria directly from urine samples. Explore how this approach simplifies workflows and accelerates time to results.

  3. Direct Amplification Of Samples Associated With Strawberry Leaf Punches 6/9/2026

    Skip extraction and still achieve reliable qPCR results. See how direct amplification of plant samples enables faster workflows, lower costs, and clear detection of resistance markers.

  4. Comprehensive And Streamlined Genomic Signature Assessment 6/9/2026

    Simultaneous analysis of HRD, TMB, and MSI offers a more complete view of tumor biology. A modular sequencing approach enables efficient workflows, conserves samples, and delivers deeper insights.

  5. Mammalian Expression 5/28/2026

    See how a biotechnology company advanced an engineered protein therapeutic while navigating development, regulatory, and scalability challenges. 

  6. Integrated Stability Workflows That Reduce Manual Data Handling 5/28/2026

    Integrated accelerated stability workflows reduce manual data handling while improving confidence in shelf‑life predictions. Help your teams move faster with fewer experimental demands.

  7. Simplify And Streamline Method Development With In Silico Modeling 5/19/2026

    Automated screening paired with in silico modeling can cut method development time while improving robustness. See how combining experimentation and simulation enables faster decision‑making.

  8. Accelerated Yield Optimization Of Affinity Capture 5/15/2026

    High‑throughput affinity screening shows how buffer and pH optimization can boost AAV5 recovery, enabling faster, more reliable downstream process development for challenging serotypes.

  9. Integrated Drug Discovery: Hit To PCC In 16 Months 5/8/2026

    Accelerate your drug discovery program with integrated, cross-functional expertise that advances promising candidates from hit identification to preclinical development with speed and efficiency.

  10. From 51% Yield To 87% With Targeted Impurity Removal 5/7/2026

    Targeted impurity identification and purification redesign dramatically improved yield, reduced process complexity, and enabled reliable API supply for Phase II clinical development.